Rebecca Chambers

Rebecca Chambers

Director of Finance/CFO at VERACYTE, INC.

Net worth: 8 M $ as of 2026-07-30

48 year
Health Technology
Consumer Services
Finance

Profile

Rebecca Chambers is currently Chief Financial Officer at Veracyte, Inc. since 2021.
Former roles include Independent Director at Inari Medical, Inc. from 2021 to 2025, Chief Financial Officer at Outset Medical, Inc. from 2019 to 2021, Director-Investor Relations & Communications at Myriad Genetics, Inc. from 2011 to 2012, Senior Manager-Investor Relations at Life Technologies Corp.
from 2009 to 2010, Senior Research Associate at Millennium Pharmaceuticals, Inc. from 1999 to 2003, Vice President at Bank of America Corp., VP-Finance, Investor Relations & Treasury at Illumina, Inc., Director at Alamar Biosciences, Inc. Education includes undergraduate studies at John Carroll University and an MBA from Johnson Graduate School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-03 173,280 ( 0.22% ) 8 M $ 2026-07-30

Rebecca Chambers active positions

CompaniesPositionStart
VERACYTE, INC. Director of Finance/CFO 2021-07-18

Former positions of Rebecca Chambers

CompaniesPositionEnd
INARI MEDICAL, INC. Director/Board Member 2025-02-18
OUTSET MEDICAL, INC. Director of Finance/CFO 2021-07-15
MYRIAD GENETICS, INC. Investor Relations Contact 2012-09-30
Public Communications Contact 2010-11-30
Corporate Officer/Principal 2002-12-31
See the detail of Rebecca Chambers's experience

Training of Rebecca Chambers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Rebecca Chambers